PETER JINDRA to Aged
This is a "connection" page, showing publications PETER JINDRA has written about Aged.
Connection Strength
0.224
-
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 May 01; 35(5):618-629.
Score: 0.059
-
Analysis of a Genetic Polymorphism in the Costimulatory?Molecule TNFSF4 with Hematopoietic Stem?Cell?Transplant Outcomes. Biol Blood Marrow Transplant. 2016 Jan; 22(1):27-36.
Score: 0.033
-
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients = 50 years from the Czech acute leukaemia clinical register (alert). Neoplasma. 2013; 60(5):576-83.
Score: 0.027
-
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma. Clin Cancer Res. 2025 Jul 01; 31(13):2639-2654.
Score: 0.016
-
Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1082-1095.e4.
Score: 0.015
-
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT. Bone Marrow Transplant. 2024 02; 59(2):224-231.
Score: 0.014
-
Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic. Neoplasma. 2020 May; 67(3):650-659.
Score: 0.011
-
Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2017 11 06; 7(1):14554.
Score: 0.010
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
Score: 0.007
-
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant. 2014 Mar; 49(3):376-81.
Score: 0.007
-
Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy. Transplantation. 2013 May 27; 95(10):1242-8.
Score: 0.007
-
[The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation]. Klin Onkol. 2012; 25(1):42-6.
Score: 0.006
-
Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience. Bone Marrow Transplant. 2012 Jun; 47(6):867-8.
Score: 0.006
-
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant. 2008 Jan; 8(1):69-77.
Score: 0.005